Scd1-flox Mouse
Common Name
Scd1-flox
제품 ID
S-CKO-04923
Backgroud
C57BL/6NCya
품종 계통계통 ID
CKOCMP-20249-Scd1-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Scd1-flox Mouse (카탈로그 번호 S-CKO-04923)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Scd1-flox
품종 계통계통 ID
CKOCMP-20249-Scd1-B6N-VA
유전자명
제품 ID
S-CKO-04923
유전자 별칭
ab, Scd, Scd-1
배경
C57BL/6NCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 19
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000041331
NCBI 전사체 ID
NM_009127
타겟 영역
Exon 3
유효 영역 크기
~0.6 kb
유전자 연구 개요
Scd1, or stearoyl-CoA desaturase 1, is a key enzyme in lipid metabolism. It desaturates saturated fatty acids (SFAs) derived from de novo lipogenesis or diet to generate monounsaturated fatty acids (MUFAs). SCD1 is involved in multiple pathways such as AMPK/ACC, SIRT1/PGC1α, and NcDase/Wnt, and is crucial for maintaining metabolic and tissue homeostasis, regulating processes like energy homeostasis, development, autophagy, tumorigenesis, and inflammation [6].
In cancer, SCD1 promotes cell proliferation and metastasis. For example, in gastric cancer, ADAR1-mediated RNA editing of SCD1 increases its mRNA stability, facilitating lipid droplet formation to alleviate chemotherapy-induced ER stress and enhancing self-renewal [3]. In ovarian cancer, SCD1 is aberrantly upregulated in ascites-derived cells, accelerating lipid metabolic activities and tumor aggressiveness, and its inhibition retards tumor growth [1]. In hepatocellular carcinoma, an SCD1-dependent mechanoresponsive pathway promotes invasion and metastasis through lipid metabolic reprogramming in response to matrix stiffness [5]. In colorectal cancer, TIGAR drives ferroptosis resistance via the ROS/AMPK/SCD1 pathway [8], and aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant cells [7]. Also, in triple-negative breast cancer, salidroside sensitizes cells to ferroptosis by inhibiting SCD1-mediated lipogenesis [4]. In non-alcoholic fatty liver disease, berberine reduces liver triglyceride synthesis and attenuates hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway [2]. Moreover, inhibition of SCD1 enhances the antitumor T cell response and synergizes with anti-PD-1 antibody [9].
In conclusion, Scd1 plays essential roles in lipid metabolism and is intricately involved in various disease conditions, especially cancer and metabolic diseases. Studies using gene-knockout or conditional-knockout mouse models (although not explicitly detailed in the provided abstracts but inferred from the general research context) would be valuable to further understand its functions in these diseases, potentially providing new therapeutic targets for treatment.
References:
1. Xuan, Yang, Wang, Huogang, Yung, Mingo Mh, Chan, Karen Kl, Chan, David W. 2022. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. In Theranostics, 12, 3534-3552. doi:10.7150/thno.70194. https://pubmed.ncbi.nlm.nih.gov/35547771/
2. Zhu, Xiaopeng, Bian, Hua, Wang, Liu, Li, Xiaoying, Gao, Xin. 2019. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. In Free radical biology & medicine, 141, 192-204. doi:10.1016/j.freeradbiomed.2019.06.019. https://pubmed.ncbi.nlm.nih.gov/31226399/
3. Wong, Tin-Lok, Loh, Jia-Jian, Lu, Shixun, Leung, Suet Yi, Ma, Stephanie. 2023. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. In Nature communications, 14, 2861. doi:10.1038/s41467-023-38581-8. https://pubmed.ncbi.nlm.nih.gov/37208334/
4. Huang, Guiqin, Cai, Yawen, Ren, Menghui, Zhu, Lingpeng, Yan, Tianhua. 2024. Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. In Journal of advanced research, , . doi:10.1016/j.jare.2024.09.027. https://pubmed.ncbi.nlm.nih.gov/39353532/
5. Liu, Hua-Hua, Xu, Yang, Li, Cao-Jie, Ren, Zheng-Gang, Chen, Rong-Xin. 2022. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. In Molecular therapy : the journal of the American Society of Gene Therapy, 30, 2554-2567. doi:10.1016/j.ymthe.2022.03.015. https://pubmed.ncbi.nlm.nih.gov/35358687/
6. Sun, Qin, Xing, Xiaorui, Wang, Huanyu, Wang, Yibing, Wang, Ru. 2023. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 170, 115586. doi:10.1016/j.biopha.2023.115586. https://pubmed.ncbi.nlm.nih.gov/38042113/
7. Chen, Hao, Qi, Qinqin, Wu, Nan, Jin, Rong, Jiang, Lei. 2022. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. In Redox biology, 55, 102426. doi:10.1016/j.redox.2022.102426. https://pubmed.ncbi.nlm.nih.gov/35963119/
8. Liu, Min-Yao, Li, Hong-Ming, Wang, Xin-Yu, Wang, Miao, Zhang, Hong-Sheng. 2022. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. In Free radical biology & medicine, 182, 219-231. doi:10.1016/j.freeradbiomed.2022.03.002. https://pubmed.ncbi.nlm.nih.gov/35271998/
9. Katoh, Yuki, Yaguchi, Tomonori, Kubo, Akiko, Suematsu, Makoto, Kawakami, Yutaka. . Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2022-004616. https://pubmed.ncbi.nlm.nih.gov/35793868/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
